Gene Review:
Nol3 - nucleolar protein 3 (apoptosis repressor...
Mus musculus
Synonyms:
ARC, B430311C09Rik, MYC, NOP, Nop30, ...
- Dominant negative MYC blocks transformation by ABL oncogenes. Sawyers, C.L., Callahan, W., Witte, O.N. Cell (1992)
- Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis. Martins, C.P., Berns, A. EMBO J. (2002)
- Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Jayachandra, S., Low, K.G., Thlick, A.E., Yu, J., Ling, P.D., Chang, Y., Moore, P.S. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations. Rockwood, L.D., Torrey, T.A., Kim, J.S., Coleman, A.E., Kovalchuk, A.L., Xiang, S., Ried, T., Morse, H.C., Janz, S. Oncogene (2002)
- Dwarfism and dysregulated proliferation in mice overexpressing the MYC antagonist MAD1. Quéva, C., McArthur, G.A., Ramos, L.S., Eisenman, R.N. Cell Growth Differ. (1999)
- Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Gavioli, E.C., Marzola, G., Guerrini, R., Bertorelli, R., Zucchini, S., De Lima, T.C., Rae, G.A., Salvadori, S., Regoli, D., Calo, G. Eur. J. Neurosci. (2003)
- Gene expression phenotypic models that predict the activity of oncogenic pathways. Huang, E., Ishida, S., Pittman, J., Dressman, H., Bild, A., Kloos, M., D'Amico, M., Pestell, R.G., West, M., Nevins, J.R. Nat. Genet. (2003)
- Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. Skorski, T., Nieborowska-Skorska, M., Campbell, K., Iozzo, R.V., Zon, G., Darzynkiewicz, Z., Calabretta, B. J. Exp. Med. (1995)
- Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. Cox, G.W., Mathieson, B.J., Gandino, L., Blasi, E., Radzioch, D., Varesio, L. J. Natl. Cancer Inst. (1989)
- Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. Marti, M., Mela, F., Fantin, M., Zucchini, S., Brown, J.M., Witta, J., Di Benedetto, M., Buzas, B., Reinscheid, R.K., Salvadori, S., Guerrini, R., Romualdi, P., Candeletti, S., Simonato, M., Cox, B.M., Morari, M. J. Neurosci. (2005)
- The MYC protein activates transcription of the alpha-prothymosin gene. Eilers, M., Schirm, S., Bishop, J.M. EMBO J. (1991)
- The protooncogene MYC can break B cell tolerance. Refaeli, Y., Field, K.A., Turner, B.C., Trumpp, A., Bishop, J.M. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Developmental stage determines the effects of MYC in the mammary epithelium. Blakely, C.M., Sintasath, L., D'Cruz, C.M., Hahn, K.T., Dugan, K.D., Belka, G.K., Chodosh, L.A. Development (2005)
- Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. Wotton, S., Stewart, M., Blyth, K., Vaillant, F., Kilbey, A., Neil, J.C., Cameron, E.R. Cancer Res. (2002)
- Conditional deletion of c-myc does not impair liver regeneration. Li, F., Xiang, Y., Potter, J., Dinavahi, R., Dang, C.V., Lee, L.A. Cancer Res. (2006)
- Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors. Flau, K., Redmer, A., Liedtke, S., Kathmann, M., Schlicker, E. Br. J. Pharmacol. (2002)
- In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. Inoue, M., Kawashima, T., Takeshima, H., Calo, G., Inoue, A., Nakata, Y., Ueda, H. J. Pharmacol. Exp. Ther. (2003)
- Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Hendy-Ibbs, P., Cox, H., Evan, G.I., Watson, J.V. Br. J. Cancer (1987)
- Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex. Mela, F., Marti, M., Ulazzi, L., Vaccari, E., Zucchini, S., Trapella, C., Salvadori, S., Beani, L., Bianchi, C., Morari, M. Eur. J. Neurosci. (2004)
- Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor. Depner, U.B., Reinscheid, R.K., Takeshima, H., Brune, K., Zeilhofer, H.U. Eur. J. Neurosci. (2003)
- The Pole3 bidirectional unit is regulated by MYC and E2Fs. Bolognese, F., Forni, C., Caretti, G., Frontini, M., Minuzzo, M., Mantovani, R. Gene (2006)
- The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism. Koizumi, M., Sakoori, K., Midorikawa, N., Murphy, N.P. Br. J. Pharmacol. (2004)
- Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation. Kansara, M., Berridge, M.V. Anticancer Res. (2004)